Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 2, 2002, Pages 496-502

  Gu, Xiaolin ^a   Samuel, Sara ^a   El Shabrawey, Mohamed ^a   Caldwell, Ruth B ^a   Bartoli, Manuela ^a   Marcus, Dennis M ^a   Brooks, Steven E ^a  

^a Eye Consultants of Augusta   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD VESSEL OCCLUSION; CELL SURVIVAL; CONTROLLED STUDY; GLIA; HYPEROXIA; IMMUNOCHEMISTRY; MOUSE; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RETINA CAPILLARY; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; REVASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPEROXIA; INFANT, NEWBORN; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; NEUROGLIA; RECURRENCE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; TIME FACTORS; VITREOUS BODY;

EID: 0036152407     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy
2. Role of astrocytes in the control of developing retinal vessels
3. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
4. Vascular endothelial growth factor (VEGF) acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
5. Development of the retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia
6. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
7. Reduced severity of oxygen-induced retinopathy in kittens recovered in 28% oxygen
8. Supplemental oxygen therapy: Basis for noninvasive treatment of retinopathy of prematurity
9. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity
10. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOPROP), a randomized, controlled trial. I: Primary outcomes
11. Oxygen-induced retinopathy in the mouse
12. eNOS deficiency reduces severity of oxygen-induced retinopathy
13. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
14. Incidence and early course of retinopathy of prematurity
15. Retinopathy of prematurity: Diagnosis, severity, and natural history
16. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
17. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor anglogen angiogenesis
18. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells
19. VEGF regulation by pH and glucose in retinal Muller cells
20. VEGF release by retinal glia depends on both oxygen and glucose supply
21. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy
22. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier
23. Astrocytes modulate retinal vasculogenesis: Effects on endothelial cell differentiation
24. Astrocytes modulate retinal vasculogenesis: Effects on fibronectin expression
25. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
26. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization